ArticleFrontiers in oncology2026

A cell death program-based tumor signature stratifies prognosis, immune landscape, and therapeutic response in glioma.

Huaichao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.